New appointment at Organovo
This article was originally published in Scrip
The San Diego-based regenerative medicine company Organovo has named Dr Marie Csete executive vice-president of R&D. She was previously chief scientific officer of the state agency, California Institute for Regenerative Medicine.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.